Differential Effects of Buprenorphine/Naloxone VS. Methadone on Quality of Life Over Time: A Subset of The BRAVO Study (Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial) is a research paper published in PDXScholar (Portland State University) (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 8RL5GM118963-02
Enhancing Cross Disciplinary Infrastructure and Training at Oregon (EXITO) Research Enrich
National Institutes of Health
Grant: 3UL1TR002369-04S2
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
National Institutes of Health
Grant: 3UG1DA015815-21S2
Medication for Opioid Use Disorder, Predictability of Retention vs Attrition
National Institutes of Health
Grant: 4R01DA037441-03
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial
Fields of Study
Sustainable Development Goals